3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
141
Lung Neoplasms
51
Pancreatic Neoplasms
30
Non-Squamous Non-Small Cell Lung Cancer
18
Neoplasms
15
Adenocarcinoma of Lung
14
Head and Neck Neoplasms
13
Glioblastoma
13
Gliosarcoma
12
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Squamous Cell
7
Carcinoma, Renal Cell
7
Astrocytoma
6
Oligodendroglioma
5
Carcinoma
5
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Glioma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
sargramostim
1
Tomography, X-Ray Computed
1
Salts
1
Radionuclide Imaging
1
Positron-Emission Tomography
1
Moxibustion
1
Magnetic Resonance Spectroscopy
1
Ibuprofen
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Fentanyl
1
FPP(RGD)2
1
Etoposide
1
Endoscopic Mucosal Resection
1
Electrocardiography
1
Doxorubicin
1
Doxepin
1
Cisplatin
1
Bevacizumab
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esthesioneuroblastoma, Olfactory
×
Erlotinib Hydrochloride
×
Clear all
No trials found.